Sui-Yuan Chang to Treatment Outcome
This is a "connection" page, showing publications Sui-Yuan Chang has written about Treatment Outcome.
Connection Strength
0.022
-
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. J Formos Med Assoc. 2021 May; 120(5):1269-1273.
Score: 0.008
-
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
Score: 0.007
-
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016; 11(12):e0169228.
Score: 0.006